Turkey / Abdi Ibrahim Buys 28.5% Stake in Swiss OM; A Historic Moment for Turkish Pharma
When Abdi Ibrahim acquired a 28.5 percent stake in Swiss biotech OM Pharma in September 2020, it represented a…
Contact Details:
Davutpasa Cad. No: 145 TR-34010
Topkapi, Istanbul
Turkey
Tel: +90 (212) 482 0000
Web: http://www.ispe.org/
When Abdi Ibrahim acquired a 28.5 percent stake in Swiss biotech OM Pharma in September 2020, it represented a…
There is perhaps no Turkish company in the healthcare sector that is more ambitious than Acıbadem. Not only has…
Dr Ferhat Farsi, CEO and founding partner of CinnaGen İlaç, shares his experience working for the largest biotech…
Şükran Tümay, a senior partner at executive search and assessment firm Stanton Chase in Turkey, highlights the…
Turkey – home to an 80 million-strong population, a substantial pharmaceuticals market and a universal healthcare…
Bucking a global trend for increased focus on outpatient and preventative care, Turkey is doubling down on…
Armağan Vurdu, general secretary of the Istanbul Minerals and Metals Exporters Association (IMMIB) highlights the…
Ozlem Fidanci, CEO of the Middle East and Turkey at Philips, shares the collaborative approach Philips has…
Yelda Ulu Colin, general manager of GE Healthcare in Turkey, offers her insider take on the country’s city…
Seizing the cost competitiveness of the Turkish market and the government’s nurturing of local manufacturing,…
Gamze Çıtıroğlu, Murat Çıtıroğlu and Pınar Çakır of Ekin Kimya discuss the progress of the Turkish…
Funda Gücer, country manager at Mylan Turkey, portrays her experience in introducing the company to the Turkish…